Primary bone marrow lymphoma: An uncommon extranodal presentation of aggressive non-hodgkin lymphomas

American Journal of Surgical Pathology

Volumn 36, Issue 2, 2012, Pages 296-304

  Martinez, Antonio ^a   Ponzoni, Maurilio ^b   Agostinelli, Claudio ^c   Hebeda, Konnie M ^d   Matutes, Estella ^e   Peccatori, Jacopo ^b   Campidelli, Cristina ^c   Espinet, Blanca ^f   Perea, Granada ^g   Acevedo, Agustin ^h   Mehrjardi, Ali Zare ⁱ   Martinez Bernal, Monica ^j   Gelemur, Marta ^k   Zucca, Emanuele ^l   Pileri, Stefano ^b   Campo, Elias ^a   López Guillermo, Armando ^a   Rozman, Maria ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c Servicio de Oncología Médica   (Spain)

^d Pathology Department   (Spain)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h ROYAL MARSDEN HOSPITAL   (United Kingdom)

ⁱ TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^j Hospital Central Mendoza   (Argentina)

^k UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^l ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

more..

Author keywords

Aggressive non Hodgkin lymphoma; B NHL; Bone lymphoma; Bone marrow; Diffuse large B cell lymphoma; Extranodal lymphoma; Follicular lymphoma; Peripheral T cell lymphoma

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW CANCER; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84857776585     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31823ea106     Document Type: Article

References (27)

1. Alvares CL, Matutes E, Scully MA, et al. Isolated bone marrow involvement in diffuse large B cell lymphoma: A report of three cases with review of morphological, immunophenotypic and cytogenetic findings. Leuk Lymphoma. 2004;45:769-775. (Pubitemid 38256040)
2. Arber DA, George TI. Bone marrow biopsy involvement by non- Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol. 2005;29:1549-1557.
3. Bain B, Matutes E, Robinson D, et al. Leukaemia as a manifestation of large cell lymphoma. Br J Hematol. 1991;77:301-310.
4. Campbell J, Seymour JF, Matthews J, et al. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement. Eur J Hematol. 2006;76: 473-480.
5. Catlett JP, Williams SA, O'Connor SC, et al. Primary lymphoma of bone: An institutional experience. Leuk Lymphoma. 2008;49: 2125-2132.
6. Chang H, Hung YS, Lin TL, et al. Primary bone marrow diffuse large B cell lymphoma: A case series and review. Ann Hematol. 2011;90:791-796.
7. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244-1253. (Pubitemid 29162950)
8. Chigrinova E, Mian M, Scandurra M, et al. Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome. Hematol Oncol. 2011;29: 38-41.
9. Choi WW, Weisenburger DD, Greiner TC, et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res. 2009;15: 5494-5502.
10. Chung R, Lai R, Wei P, et al. Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index. Blood. 2007;110:1278-1282. (Pubitemid 47281426)
11. Colomo L, Lopez-Guillermo A, Perales M, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood. 2003;101:78-84. (Pubitemid 36025890)
12. de LL, Braaten KM, Ancukiewicz M, et al. Diffuse large B-cell lymphoma of bone: An analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol. 2003;27:1269-1277. (Pubitemid 37040590)
13. Hishizawa M, Okamoto K, Chonabayashi K, et al. Primary large B-cell lymphoma of the bone marrow. Br J Hematol. 2007;136:351-796.
14. Kajiura D, Yamashita Y, Mori N. Diffuse large B-cell lymphoma initially manifesting in the bone marrow. Am J Clin Pathol. 2007;127:762-769.
15. Kong SY, Cho EH, Woo HY, et al. De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean. J Korean Med Sci. 2004;19:815-819. (Pubitemid 40104873)
16. Kremer M, Spitzer M, Mandl-Weber S, et al. Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders. Lab Invest. 2003;83:107-114. (Pubitemid 36126055)
17. Meyer PN, Fu K, Greiner TC, et al. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol. 2011;29: 200-207.
18. Paone G, Itti E, Haioun C, et al. Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate. Eur J Nucl Med Mol Imaging. 2009;36:745-750.
19. Ponzoni M, Li CY. Isolated bone marrow non-Hodgkin's lymphoma: A clinicopathologic study. Mayo Clin Proc. 1994;69:37-43.
20. Sehn LH, Scott DW, Chhanabhai M, et al. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol. 2011;29: 1452-1457.
21. Strauchen JA. Primary bone marrow B-cell lymphoma: report of four cases. Mt Sinai J Med. 2003;70:133-138. (Pubitemid 36322205)
22. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
23. Taniguchi M, Oka K, Hiasa A, et al. De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood. 1998;91:1145-1151. (Pubitemid 28086866)
24. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317. (Pubitemid 38072572)
25. Wong KF, Chan JK, Ng CS, et al. Large cell lymphoma with initial presentation in the bone marrow. Hematol Oncol. 1992;10: 261-271. (Pubitemid 23050933)
26. Yamaguchi M, Seto M, Okamoto M, et al. De novo CD5+ diffuse large B-cell lymphoma: A clinicopathologic study of 109 patients. Blood. 2002;99:815-821. (Pubitemid 34525540)
27. Yi S, An G, Qi J, et al. The significance of bone marrow involvement in aggressive lymphomas: A retrospective comparison of clinical outcomes between peripheral T cell lymphoma and diffuse large B cell lymphoma in China. Acta Hematol. 2010;124:239-244.